Are pregnancy rates compromised following embryo freezing to prevent OHSS?

Ulster Medical Journal

Volumn 77, Issue 3, 2008, Pages 164-167

  Fitzmaurice, Gerard J ^a   Boylan, Claire ^b   McClure, Neil ^c,d  

^a DAISY HILL HOSPITAL   (United Kingdom)

^b CRAIGAVON AREA HOSPITAL   (United Kingdom)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d ROYAL MATERNITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOPRESERVATION; DISEASE COURSE; EMBRYO TRANSFER; FEMALE; FREEZING; HUMAN; INCIDENCE; INFERTILITY THERAPY; INTERMETHOD COMPARISON; MALE INFERTILITY; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; PREGNANCY OUTCOME; PREGNANCY RATE; PREGNANCY TEST; RETROSPECTIVE STUDY; TREATMENT INDICATION;

CRYOPRESERVATION; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMANS; INCIDENCE; NORTHERN IRELAND; OVARIAN HYPERSTIMULATION SYNDROME; PREGNANCY; PREGNANCY RATE; RETROSPECTIVE STUDIES;

EID: 57149114750     PISSN: 00416193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. National Collaborating Centre for Women's, Children's Health. Fertility: assessment and treatment for people with fertility problems. Nice Clinical Guidelines, 11. National Institute for Clinical Excellence. 2004. p. 81-106. Available from: http://www.nice.org.uk/nicemedia/pdf/CG011niceguideline.pdf. Last accessed June 2008.
2. Davis M, Kennedy R. Ovarian hyperstimulation syndrome: aetiology, prevention and management. Rev Gynaecol Perinat Pract 2006; 6(2):26-32.
3. McElhinney B, McClure N. Ovarian hyperstimulation syndrome. Bailliere's Best Pract Res Clin Obstet Gynaecol 2000; 14(1):103-22.
4. Roest J, Mous HV, Zeilmaker GH, Verhoeff A. The incidence of major clinical complications in a Dutch transport IVF programme. Hum Reprod Update 1996;2(4):345-53.
5. Whelan JG, Vlahos NF. The ovarian hyperstimulation syndrome. Fertil Steril 2000;73(5):883-96.
6. Govaerts I, Devreker F, Delbaere A, Revelard Ph, Englert Y. Short-term medical complications of 1,500 oocyte retrievals for in vitro fertilisation and embryo transfer. Europ J Obstet Gynecol Reprod Biol 1998; 77(2):239-43.
7. Klemetti R, Sevon T, Gissler M, Hemminke E. Complications of IVF and ovulation induction. Hum Reprod 2005;20(12):3293-300.
8. Papanikolaou EG, Pozzobon C, Kolibianakis EM, Camus M, Tournaye H, Fatemi HM, et al. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotrophin releasing hormone antagonist in vitro fertilisation cycles. Fertil Steril 2006;85(1):112-20.
9. Cremisi HD, Mitch WE. Profound hypotension and sodium retention with the ovarian hyperstimulation syndrome. Am J Kidney Dis 1994; 24(5):854-7.
10. Abramov Y, Elchalal U, Schenker JG. Obstetric outcome of in vitro fertilised pregnancies complicated by severe ovarian hyperstimulation syndrome: a multicenter study. Fertil Steril 1998; 70(6):1070-6.
11. Mathur RS, Akande AV, Keay SD, Hunt LP, Jenkins JM. Distinction between early and late ovarian hyperstimulation syndrome. Fertil Steril 2000;73(5):901-7.
12. Schenker JG. Clinical aspects of ovarian hyperstimulation syndrome. Eur J Obstet Gynecol Reprod Biol 1999;85(1):13-20.